Alan C. Wagner

2.4k citations

23 papers · 2.1k indexed · h-index 21

Impact in

Clinical Biochemistry top 1%
- Paraoxonase enzyme and polymorphisms
Endocrinology, Diabetes and Metabolism top 2%
- Diabetes, Cardiovascular Risks, and Lipoproteins

Papers in

Clinical Biochemistry 5
- Paraoxonase enzyme and polymorphisms 5
Biochemistry 3

Co-authors: Alan M. Fogelman Mohamad Navab Brian J. Van Lenten Susan Hama Srinivasa T. Reddy G.M. Anantharamaiah Greg Hough Víctor Grijalva
Journals: Journal of Lipid Research (8 papers)Circulation (4 papers)Arteriosclerosis Thrombosis and Vascular Biology (3 papers)Journal of Biological Chemistry (1 paper)Current Atherosclerosis Reports (1 paper)
Partner nations: United States Poland Canada

In The Last Decade

Alan C. Wagner

23 papers receiving 2.0k citations

Peers

Countries citing papers authored by Alan C. Wagner

Since Specialization

Citations

This map shows the geographic impact of Alan C. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan C. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan C. Wagner more than expected).

Fields of papers citing papers by Alan C. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan C. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan C. Wagner. The network helps show where Alan C. Wagner may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan C. Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan C. Wagner Line = papers co-authored together Alan C. Wagner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice Journal of Lipid Research ·Keiichi Karasawa, Greg Hough, A. Chattopadhyay, Víctor Grijalva, Ellen O’Connor, David Meriwether, Alan C. Wagner, James M. Ntambi, Mohamad Navab, Srinivasa T. Reddy, Alan M. Fogelman	2018	12
2	Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux Journal of Lipid Research ·David Meriwether, Dawoud Sulaiman, Alan C. Wagner, Víctor Grijalva, Izumi Kaji, Kevin J. Williams, Liqing Yu, B. Piasecki, Evan G. Tryon, Steven J. Bensinger, G.M. Anantharamaiah, Ishaiahu Shechter, Alan M. Fogelman, Srinivasa T. Reddy	2016	20
3	Apolipoprotein E ^−/− Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function Arteriosclerosis Thrombosis and Vascular Biology ·Jos Andenaes, Víctor Grijalva, Susan Hama, Alan C. Wagner, Mohamad Navab, Alan M. Fogelman, Srinivasa T. Reddy	2016	28
4	Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis Journal of Lipid Research ·Mohamad Navab, A. Chattopadhyay, Greg Hough, David Meriwether, B. Piasecki, Alan C. Wagner, Víctor Grijalva, Feng Su, G.M. Anantharamaiah, Lin Hwang, Kym F. Faull, Srinivasa T. Reddy, Alan M. Fogelman	2015	41
5	A novel approach to oral apoA-I mimetic therapy Journal of Lipid Research ·A. Chattopadhyay, Mohamad Navab, Greg Hough, Feng Gao, David Meriwether, Víctor Grijalva, James R. Springstead, Nina A. Akovbian, Milja Räisänen, Feng Su, Brian J. Van Lenten, Alan C. Wagner, G.M. Anantharamaiah, Robin Farias‐Eisner, Srinivasa T. Reddy, Alan M. Fogelman	2013	73
6	Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid Journal of Lipid Research ·Mohamad Navab, Greg Hough, Georgette M. Buga, Feng Su, Alan C. Wagner, David Meriwether, A. Chattopadhyay, Feng Gao, Víctor Grijalva, María Paula Acero Triviño, Brian J. Van Lenten, Elin Org, Aldons J. Lusis, Calvin Pan, G.M. Anantharamaiah, Robin Farias‐Eisner, Susan S. Smyth, Srinivasa T. Reddy, Alan M. Fogelman	2013	58
7	LXRα is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice Journal of Lipid Research ·Cynthia Hong, J Kohlícek, Xin Rong, Xuping Wang, Alan C. Wagner, Víctor Grijalva, Lawrence W. Castellani, Jon Salazar, Susan Realegeno, Rima Boyadjian, Alan M. Fogelman, Brian J. Van Lenten, Srinivasa T. Reddy, Aldons J. Lusis, Rajendra K. Tangirala, Peter Tontonoz	2012	37
8	High-Density Lipoprotein and 4F Peptide Reduce Systemic Inflammation by Modulating Intestinal Oxidized Lipid Metabolism Arteriosclerosis Thrombosis and Vascular Biology ·Mohamad Navab, Srinivasa T. Reddy, Brian J. Van Lenten, Georgette M. Buga, Greg Hough, Alan C. Wagner, Alan M. Fogelman	2012	57
9	L-4F Differentially Alters Plasma Levels of Oxidized Fatty Acids Resulting in more Anti-Inflammatory HDL in Mice Drug Metabolism Letters ·Satoshi Imaizumi, Víctor Grijalva, Mohamad Navab, Brian J. Van Lenten, Alan C. Wagner, Wilmer Alirio Tovar Tovar, Alan M. Fogelman, Srinivasa T. Reddy	2010	48
10	Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer Proceedings of the National Academy of Sciences ·Feng Su, V. Büchel, Satoshi Imaizumi, Feng Gao, M. Amneus, Víctor Grijalva, Carey J. Ng, Alan C. Wagner, Greg Hough, Gina Farias-Eisner, G.M. Anantharamaiah, Brian J. Van Lenten, Mohamad Navab, Alan M. Fogelman, Srinivasa T. Reddy, Robin Farias‐Eisner	2010	170
11	Apolipoprotein A-I mimetic peptides Current Atherosclerosis Reports ·Brian J. Van Lenten, Alan C. Wagner, G.M. Anantharamaiah, Mohamad Navab, Srinivasa T. Reddy, Georgette M. Buga, Alan M. Fogelman	2008	73
12	Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis Clinical Immunology ·Christina Charles‐Schoeman, Mona Lisa Banquerigo, Susan Hama, Mohamad Navab, Grace S. Park, Brian J. Van Lenten, Alan C. Wagner, Alan M. Fogelman, Ernest Brahn	2008	41
13	Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I Journal of Lipid Research ·Brian J. Van Lenten, Alan C. Wagner, Chun‐Ling Jung, Piotr Ruchała, Alan J. Waring, Robert I. Lehrer, Andrew D. Watson, Susan Hama, Mohamad Navab, G.M. Anantharamaiah, Alan M. Fogelman	2008	159
14	Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits Journal of Lipid Research ·Brian J. Van Lenten, Alan C. Wagner, Mohamad Navab, G.M. Anantharamaiah, Susan Hama, Srinivasa T. Reddy, Alan M. Fogelman	2007	91
15	The double jeopardy of HDL Annals of Medicine ·Mohamad Navab, Magnus E. Johnson, Srinivasa T. Reddy, Brian J. Van Lenten, Benjamin J. Ansell, Susan Hama, Greg Hough, B. F. C. Bauermann, Víctor Grijalva, Alan C. Wagner, Zory Shaposhnik, Alan M. Fogelman	2005	116
16	An Oral ApoJ Peptide Renders HDL Antiinflammatory in Mice and Monkeys and Dramatically Reduces Atherosclerosis in Apolipoprotein E–Null Mice Arteriosclerosis Thrombosis and Vascular Biology ·Mohamad Navab, G.M. Anantharamaiah, Srinivasa T. Reddy, Brian J. Van Lenten, Alan C. Wagner, Susan Hama, Greg Hough, B. F. C. Bauermann, David W. Garber, Vinod Mishra, Mayakonda N. Palgunachari, Alan M. Fogelman	2005	98
17	Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis. PubMed ·Mohamad Navab, G.M. Anantharamaiah, Philip Becnel, Cássio Slompo Ramos, Greg Hough, Alan C. Wagner, Kenta Nakamura, Karin Elbrecht, Geeta Datta, Julie Allan, Susan Hama, Alan M. Fogelman	2003	28
18	Influenza Infection Promotes Macrophage Traffic Into Arteries of Mice That Is Prevented by D-4F, an Apolipoprotein A-I Mimetic Peptide Circulation ·Brian J. Van Lenten, Alan C. Wagner, G.M. Anantharamaiah, David W. Garber, Michael C. Fishbein, Lopa Adhikary, Debi P. Nayak, Susan Hama, Mohamad Navab, Alan M. Fogelman	2002	149
19	Oxidized Phospholipids Induce Changes in Hepatic Paraoxonase and ApoJ but Not Monocyte Chemoattractant Protein-1 via Interleukin-6 Journal of Biological Chemistry ·Brian J. Van Lenten, Alan C. Wagner, Mohamad Navab, Alan M. Fogelman	2001	104
20	[Comparative studies of the response of normolipemic and dyslipemic aged subjects to 2 forms of delayed-action nicotinic acid polyesters. Pentaerythrotol tetranicotinate and inositol hexanicotinate. Results of a controlled cross-over trial]. PubMed ·Ethan Tabaie, Gaetano Lamberti, Alan C. Wagner, L Cima, 斎藤太一	1978	8

About Alan C. Wagner

Alan C. Wagner is a scholar working on Clinical Biochemistry, Biochemistry, Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics and Surgery, having authored 23 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (9 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Paraoxonase enzyme and polymorphisms (5 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Lipid metabolism and disorders (3 papers), Fatty Acid Research and Health (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Clinical Biochemistry (311 citations), Endocrinology, Diabetes and Metabolism (616 citations), Cancer Research (383 citations), Surgery (937 citations) and Immunology (445 citations). Alan C. Wagner has collaborated with scholars based in United States, Poland and Canada. Frequent co-authors include Alan M. Fogelman, Mohamad Navab, Brian J. Van Lenten, Susan Hama, Srinivasa T. Reddy, G.M. Anantharamaiah, Greg Hough, Víctor Grijalva, Debi P. Nayak and David W. Garber. Their work appears in journals such as Journal of Lipid Research, Circulation, Arteriosclerosis Thrombosis and Vascular Biology, Journal of Biological Chemistry and Current Atherosclerosis Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact